Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
7.2
Journals
JPM
Announcements
share announcement

Announcements

24 October 2025
Journal of Personalized Medicine | Scope Update

To continue advancing the standard of the Journal of Personalized Medicine (JPM, ISSN: 2075-4426), the journal has refined its scope under the guidance of Editor-in-Chief Prof. Dr. Kenneth P. H. Pritzker. Please find the original and new scope listed below.

Scope (new version):

Scope (old version):

JPM particularly encourages submissions that focus on the following topics within its scope:

Topics of interest with a view towards personalized medicine include (but are not limited to) the following:
  • Novel and emerging informatics applied to personalized medicine, including well-grounded artificial intelligence/machine learning-enabled methods;
  • Diagnostic characteristics for disease subtypes, or evidence for groups of patients who are likely to respond to therapy vs. those who do not;
  • Processes such as organ/tissue transplantation, where de-personalizing donor tissue results in broader positive outcomes for recipients.

Papers that may be considered out of scope include the following:

  • Method papers that do not describe subpopulations where their approaches might be most or least effective;
  • Reports and theoretical studies with broad implications only

 

 

 

 

 

 

  
  • Omics-based studies of disease risk, disease prognosis, and response to therapy;
  • Biomarker identification and application;
  • Drug target discovery and integration with individualized therapy;
  • Pharmacogenomics—the genetics and biochemistry of drug uptake, action, and metabolism;
  • Prediction-based drug safety;
  • Novel therapeutics: genetic-based, nanotechnology, targeting strategies;
  • Advancements in Technologies and Resources, including the following:
    • Genetic testing, sequencing technologies, and molecular diagnostics;
    • Expression analysis, metabolomics, proteomics
    • Microbiomes;
    • Genome-wide association studies;
    • Bioinformatics and health informatics;
    • Biostatistics.
  • Personalization of omics-based non-drug-related health interventions;
  • Regulation and bioethics in personalized medicine.

For more detailed information, please visit the following link: https://www.mdpi.com/journal/jpm/about.

JPM Editorial Office

More News...
Back to TopTop